- Home
- TPCS vs ELEV Comparison
TPCS vs ELEV Comparison
Compare TPCS & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- ELEV
- Stock Information
- Founded
- TPCS 1956
- ELEV 2019
- Country
- TPCS United States
- ELEV United States
- Employees
- TPCS N/A
- ELEV N/A
- Industry
- TPCS Metal Fabrications
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- ELEV Health Care
- Exchange
- TPCS Nasdaq
- ELEV Nasdaq
- Market Cap
- TPCS 31.5M
- ELEV 37.6M
- IPO Year
- TPCS N/A
- ELEV 2021
- Fundamental
- Price
- TPCS $3.20
- ELEV $0.64
- Analyst Decision
- TPCS
- ELEV Buy
- Analyst Count
- TPCS 0
- ELEV 6
- Target Price
- TPCS N/A
- ELEV $7.20
- AVG Volume (30 Days)
- TPCS 25.4K
- ELEV 4.6M
- Earning Date
- TPCS 01-21-2025
- ELEV 03-05-2025
- Dividend Yield
- TPCS N/A
- ELEV N/A
- EPS Growth
- TPCS N/A
- ELEV N/A
- EPS
- TPCS N/A
- ELEV N/A
- Revenue
- TPCS $33,182,059.00
- ELEV N/A
- Revenue This Year
- TPCS N/A
- ELEV N/A
- Revenue Next Year
- TPCS N/A
- ELEV N/A
- P/E Ratio
- TPCS N/A
- ELEV N/A
- Revenue Growth
- TPCS 6.44
- ELEV N/A
- 52 Week Low
- TPCS $2.85
- ELEV $0.50
- 52 Week High
- TPCS $5.95
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- TPCS 46.13
- ELEV 48.18
- Support Level
- TPCS $3.06
- ELEV $0.60
- Resistance Level
- TPCS $3.25
- ELEV $0.74
- Average True Range (ATR)
- TPCS 0.14
- ELEV 0.07
- MACD
- TPCS 0.00
- ELEV -0.01
- Stochastic Oscillator
- TPCS 50.00
- ELEV 28.55
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.